PTGIS
PTGIS (prostaglandin I2 synthase, also known as PGIS or CYP8A1) is an endoplasmic reticulum membrane enzyme that converts prostaglandin H2 to prostacyclin. Prostacyclin is a potent vasodilator and an inhibitor of platelet aggregation. Browse Assay Genie's current range of PTGIS research reagents below, or read on for the biology behind the target.
PTGIS, or prostacyclin synthase, catalyses the biosynthesis and metabolism of eicosanoids. Its best-characterised reaction is the isomerisation of prostaglandin H2 to prostacyclin (prostaglandin I2), a potent mediator of vasodilation and inhibitor of platelet aggregation. The enzyme also has dehydratase activity towards hydroperoxyeicosatetraenoates (HPETEs), especially (15S)-hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoate, known as 15(S)-HPETE.
The PTGIS gene encodes a member of the cytochrome P450 superfamily. Cytochrome P450 proteins are generally monooxygenases that act in drug metabolism and in the synthesis of cholesterol, steroids and other lipids. PTGIS is placed in the family on the basis of sequence similarity rather than functional similarity, since it acts as an isomerase and dehydratase. HGNC classifies it in cytochrome P450 family 8 and among the hydroperoxy icosatetraenoate dehydratases. The protein is anchored in the endoplasmic reticulum membrane. Orthologous genes, named Ptgis, are annotated in both mouse and rat.
The gene was formerly named prostaglandin I2 (prostacyclin) synthase, and the symbols PGIS and CYP8A1 are still found in the literature. Prostacyclin has a physiological antagonist, thromboxane A2. An imbalance between the two contributes to the development of myocardial infarction, stroke and atherosclerosis, which is why PTGIS is of interest in cardiovascular and vascular biology research.
PTGIS produces prostacyclin, and an imbalance with thromboxane A2 contributes to myocardial infarction, stroke and atherosclerosis.
The enzyme generates a potent vasodilator and inhibitor of platelet aggregation, making it central to studies of vascular tone.
PTGIS isomerises prostaglandin H2 and dehydrates HPETEs such as 15(S)-HPETE, linking it to wider eicosanoid biosynthesis.
Classed as a P450 by sequence rather than function, PTGIS offers a useful contrast with monooxygenase members of the superfamily.
PTGIS catalyses the isomerisation of prostaglandin H2 to prostacyclin (prostaglandin I2), a potent vasodilator and inhibitor of platelet aggregation. It also dehydrates hydroperoxyeicosatetraenoates, especially 15(S)-HPETE, and so contributes to eicosanoid biosynthesis and metabolism at the endoplasmic reticulum membrane.
PTGIS is the HGNC symbol for prostaglandin I2 synthase. UniProt names the protein prostacyclin synthase. Aliases and previous symbols include PGIS and CYP8A1, and an earlier gene name was prostaglandin I2 (prostacyclin) synthase. Its enzyme classification is EC 5.3.99.4.
PTGIS belongs to the cytochrome P450 superfamily by sequence similarity, not functional similarity, as typical P450s are monooxygenases. Mouse and rat both carry an orthologous gene, Ptgis. Check the datasheet of any product for its validated reactivity.
Other prostaglandin synthases, eicosanoid receptors and cardiovascular pathway targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q16647; product specifications from Assay Genie datasheets.